JFL Life Sciences Limited (NSE:JFLLIFE)
India · Delayed Price · Currency is INR 11.80
+0.55 (4.89%)
At close: Jul 28, 2026
JFL Life Sciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 14.62 | 0.64 | 4.41 | 0.6 | 1.9 |
Cash & Short-Term Investments | 14.62 | 0.64 | 4.41 | 0.6 | 1.9 |
Cash Growth | 2188.11% | -85.51% | 635.17% | -68.42% | 375.00% |
Accounts Receivable | 532.61 | 349.45 | 258.47 | 224.6 | 198.1 |
Other Receivables | 0.25 | 0.02 | 0.27 | 0.3 | 0.9 |
Receivables | 532.85 | 349.47 | 258.74 | 224.9 | 199 |
Inventory | 345.48 | 232.41 | 158.33 | 127.2 | 149.6 |
Prepaid Expenses | - | - | - | - | 0.1 |
Other Current Assets | 22.05 | 12.52 | 14.54 | 58.6 | 42.3 |
Total Current Assets | 915 | 595.04 | 436.02 | 411.3 | 392.9 |
Property, Plant & Equipment | 145.4 | 122.36 | 124.74 | 68 | 71.3 |
Long-Term Deferred Tax Assets | - | - | 1.22 | - | - |
Other Long-Term Assets | 2.06 | 1.74 | 5.12 | 11.3 | 18.4 |
Total Assets | 1,062 | 719.14 | 567.1 | 490.6 | 482.6 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 292.83 | 177.57 | 125.14 | 73.9 | 154.4 |
Accrued Expenses | - | 3.61 | 0.8 | 3.1 | 1.2 |
Short-Term Debt | 148.47 | 102.1 | 52.9 | 57.9 | 53.8 |
Current Portion of Long-Term Debt | - | - | - | - | 20.6 |
Current Income Taxes Payable | 42.99 | 21.82 | 16.78 | 9.8 | 10.6 |
Current Unearned Revenue | - | 10.35 | 10.15 | - | - |
Other Current Liabilities | 45.6 | 0.75 | 0.5 | 7.5 | 43.2 |
Total Current Liabilities | 529.88 | 316.22 | 206.28 | 152.2 | 283.8 |
Long-Term Debt | 68.82 | 3.8 | 4.02 | 13.9 | 84.1 |
Pension & Post-Retirement Benefits | 1.39 | 1.3 | 1.04 | - | - |
Long-Term Deferred Tax Liabilities | 3.67 | 3.27 | - | 1.8 | 1.8 |
Total Liabilities | 603.77 | 324.59 | 211.35 | 167.9 | 369.7 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 329.95 | 329.95 | 109.98 | 110 | 80.2 |
Additional Paid-In Capital | - | - | 156.47 | 156.5 | 4.6 |
Retained Earnings | 128.74 | 64.6 | 89.3 | 56.2 | 28.1 |
Shareholders' Equity | 458.69 | 394.55 | 355.75 | 322.7 | 112.9 |
Total Liabilities & Equity | 1,062 | 719.14 | 567.1 | 490.6 | 482.6 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 217.29 | 105.9 | 56.92 | 71.8 | 158.5 |
Net Cash (Debt) | -202.67 | -105.26 | -52.51 | -71.2 | -156.6 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -6.14 | -3.19 | -1.59 | -2.45 | -7.66 |
Filing Date Shares Outstanding | 33.17 | 33 | 33 | 33 | 24.06 |
Total Common Shares Outstanding | 33.17 | 33 | 33 | 33 | 24.06 |
Working Capital | 385.12 | 278.83 | 229.74 | 259.1 | 109.1 |
Book Value Per Share | 13.83 | 11.96 | 10.78 | 9.78 | 4.69 |
Tangible Book Value | 458.69 | 394.55 | 355.75 | 322.7 | 112.9 |
Tangible Book Value Per Share | 13.83 | 11.96 | 10.78 | 9.78 | 4.69 |
Land | - | - | - | 28.5 | 28.5 |
Buildings | - | 43.87 | 43.87 | 4.7 | 4.8 |
Machinery | - | 65.94 | 58.39 | 56 | 55 |